These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31309933)

  • 1. [Legal protection of employee health when working with nanoparticles. Comments on the appropriateness of introducing european legal regulations].
    Jarota M
    Med Pr; 2019 Sep; 70(5):633-647. PubMed ID: 31309933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Legal aspects of workers' health protection against asbestos in Poland in the light of the EU legal framework].
    Swiatkowska B
    Med Pr; 2013; 64(5):689-97. PubMed ID: 24502132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marijuana in the Workplace: Guidance for Occupational Health Professionals and Employers: Joint Guidance Statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine.
    Phillips JA; Holland MG; Baldwin DD; Gifford-Meuleveld L; Mueller KL; Perkison B; Upfal M; Dreger M
    Workplace Health Saf; 2015 Apr; 63(4):139-64. PubMed ID: 25862727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regulations for the protection of workers against the effects of hazardous substances at the workplace].
    Wolf T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Mar; 51(3):266-73. PubMed ID: 18369561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Legal regulations of occupational skin protection.
    Schmidt A
    Int Arch Occup Environ Health; 2003 Jun; 76(5):400-3. PubMed ID: 12811571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The traceability of carcinogenic occupational risks: state of progress in France compared with other European countries.
    Fantoni-Quinton S; Frimat P
    Med Law; 2010 Dec; 29(4):467-86. PubMed ID: 22145545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Occupational exposure to biological agents and the protection of exposed workers according to the new legal regulations].
    Zielińska-Jankiewicz K; Kozajda A; Szadkowska-Stańczyk I
    Med Pr; 2005; 56(4):319-23. PubMed ID: 16457370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Health protection of a worker exposed to chemical agents in the work environment - biological monitoring in health risk assessment: legal regulations].
    Gregorczyk R; Janasik B; Smuga J
    Med Pr; 2022 Sep; 73(4):349-356. PubMed ID: 35997387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Croatian and international regulations on the protection and rights of workers exposed to asbestos at work].
    Zavalić M; Macan J
    Arh Hig Rada Toksikol; 2009 Nov; 60 Suppl():57-63. PubMed ID: 20853780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial intelligence and robotisation in the EU - should we change OHS law?
    Jarota M
    J Occup Med Toxicol; 2021 May; 16(1):18. PubMed ID: 33952297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-occupational but work-related diseases - Legislation, judicature and potential implications to employers and employees in Poland].
    Marcinkiewicz A; Tomczak P; Wiszniewska M; Walusiak-Skorupa J; Dorre-Kolasa D
    Med Pr; 2018 Oct; 69(5):539-546. PubMed ID: 30057420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The 20th century legal framework regarding risk at work and occupational health in Colombia].
    Arango-Soler JM; Luna-García JE; Correa-Moreno YA; Campos AC
    Rev Salud Publica (Bogota); 2013; 15(3):354-65. PubMed ID: 25123994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory approaches to worker protection in nanotechnology industry in the USA and European union.
    Murashov V; Schulte P; Geraci C; Howard J
    Ind Health; 2011; 49(3):280-96. PubMed ID: 21372443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The implementation of legislation acts regarding prevention of occupational exposure to bloodborne pathogens from perspective of Poland as the ue country].
    Szczeniowski A; Gańczak M
    Med Pr; 2011; 62(1):57-66. PubMed ID: 21748884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dealing with uncertainties in the nanotech workplace practice: making the precautionary approach operational.
    van Broekhuizen P
    J Biomed Nanotechnol; 2011 Feb; 7(1):15-7. PubMed ID: 21485779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A review of measures taken to improve organizational wellbeing in Italy].
    Bentivenga R; Deitinger P; Ghelli M
    G Ital Med Lav Ergon; 2014; 36(1):54-64. PubMed ID: 24665629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of U.S. regulations on determination of work-relatedness of mental health disturbance and cerebrovascular and cardiac diseases].
    Suemitsu T; Okufuji T; Miyazaki S; Horie S
    Sangyo Eiseigaku Zasshi; 2007 Jan; 49(1):27-34. PubMed ID: 17303936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occupational health practice and exposure to nanoparticles: reconciling scientific evidence, ethical aspects, and legal requirements.
    Franco G
    Arch Environ Occup Health; 2011; 66(4):236-40. PubMed ID: 22014197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noise exposure and hearing loss prevention programmes after 20 years of regulations in the United States.
    Daniell WE; Swan SS; McDaniel MM; Camp JE; Cohen MA; Stebbins JG
    Occup Environ Med; 2006 May; 63(5):343-51. PubMed ID: 16551755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Employer's obligation of safety and nanomaterials].
    Doucet M
    J Int Bioethique; 2011; 22(1):173-84, 217. PubMed ID: 21850977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.